Regulatory Brief: USP 382 Updates

The regulatory landscape for pharmaceutical and combination products continues to evolve, with increasing efforts toward global harmonization across agencies and standards organizations. While many requirements align in principle, subtle differences can create complexity for manufacturers navigating compliance. One such example involves recent updates to guidance on testing elastomeric container closure systems, where differing expectations around performance testing have prompted industry discussion.

These variations highlight the broader challenge of ensuring testing approaches accurately reflect real-world use while still meeting stringent regulatory expectations. In response, updates to compendial standards aim to better align requirements and provide clearer direction for evaluating system integrity and performance.

As regulations continue to shift, staying current with the latest expectations is essential for maintaining compliance and ensuring patient safety. Whether testing is performed internally or through external partners, a thorough understanding of evolving standards plays a critical role in successful product development and lifecycle management.